Asia
SciVision Biotech's Joint Injections Get Medical Device Licenses in Panama
SciVision Biotech's (TPE:1786) one-injection and three-injection hyaluronic acid synovial fluid products obtained medical device licenses in Panama, according to a Friday Taiwan Exchange filing.The products, FLEXVISC PLUS and FLEXVISC, improve joint lubrication and reduce friction. They also help relieve osteoarthritis pain and improve mobility, the company said.
TPE:1786
